Literature DB >> 2926439

Congenital nemaline myopathy. A clinical follow-up of twelve patients.

C Wallgren-Pettersson1.   

Abstract

A clinical follow-up of 12 patients with congenital nemaline myopathy (CNM) is reported. The aims of the study were to characterise the disease further, to investigate the prognosis of CNM and the factors influencing it, to find guidelines for treatment and, through neuropsychological tests, electroencephalography and computed tomography of the head, to determine whether the central nervous system is affected. The following distribution of muscular weakness was constantly found: the weakest muscles were the facial muscles, the flexors of the neck and trunk, the dorsiflexors of the feet and the extensors of the toes. The distal limb muscles and the limb-girdle muscles were clearly weaker than the proximal limb muscles. No signs of involvement of the central nervous system were detected, and IQs showed a skew towards higher levels. The clinical state of health had deteriorated in 10 of the 12 patients and improved in 2. In addition to the grade of disease activity, prognosis seemed to be influenced mainly by the development of scoliosis and by the restricted respiratory capacity. Since no specific therapy is available for this disease, recommendations for the management of CNM include active rehabilitation and vigorous treatment of respiratory infections. Physiotherapy should focus especially on the maintenance of cardiorespiratory capacity and the prevention and treatment of scoliosis. Long periods of immobilisation should be avoided.

Entities:  

Mesh:

Year:  1989        PMID: 2926439     DOI: 10.1016/0022-510x(89)90002-6

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  10 in total

Review 1.  Nemaline myopathy: current concepts. The ENMC International Consortium and Nemaline Myopathy.

Authors:  K N North; N G Laing; C Wallgren-Pettersson
Journal:  J Med Genet       Date:  1997-09       Impact factor: 6.318

2.  Respiratory deterioration during growth hormone therapy in a case of congenital nemaline myopathy.

Authors:  K Logghe; J M Wit; F Jennekens; J E Pruijs
Journal:  Eur J Pediatr       Date:  1990-11       Impact factor: 3.183

3.  Follow-up studies in a case of unusual congenital myopathy, suggestive of nemaline type.

Authors:  E Gibbels; K Kellermann; H J Schädlich; R Adams; W F Haupt
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

4.  Exclusion of two candidate loci for autosomal recessive nemaline myopathy.

Authors:  E Tahvanainen; A H Beggs; C Wallgren-Pettersson
Journal:  J Med Genet       Date:  1994-01       Impact factor: 6.318

5.  Genetics of congenital nemaline myopathy: a study of 10 families.

Authors:  C Wallgren-Pettersson; H Kääriäinen; J Rapola; T Salmi; J Jääskeläinen; M Donner
Journal:  J Med Genet       Date:  1990-08       Impact factor: 6.318

Review 6.  Pathophysiological concepts in the congenital myopathies: blurring the boundaries, sharpening the focus.

Authors:  Gianina Ravenscroft; Nigel G Laing; Carsten G Bönnemann
Journal:  Brain       Date:  2014-12-31       Impact factor: 13.501

7.  Cytoplasmic body pathology in severe ACTA1-related myopathy in the absence of typical nemaline rods.

Authors:  Sandra Donkervoort; Sophelia H S Chan; Leslie H Hayes; Nathaniel Bradley; David Nguyen; Meganne E Leach; Payam Mohassel; Ying Hu; Mathula Thangarajh; Diana Bharucha-Goebel; Amanda Kan; Ronnie S L Ho; Christine A Reyes; Jessica Nance; Steven A Moore; A Reghan Foley; Carsten G Bönnemann
Journal:  Neuromuscul Disord       Date:  2017-03-02       Impact factor: 4.296

8.  Mutation update: the spectra of nebulin variants and associated myopathies.

Authors:  Vilma-Lotta Lehtokari; Kirsi Kiiski; Sarah A Sandaradura; Jocelyn Laporte; Pauliina Repo; Jennifer A Frey; Kati Donner; Minttu Marttila; Carol Saunders; Peter G Barth; Johan T den Dunnen; Alan H Beggs; Nigel F Clarke; Kathryn N North; Nigel G Laing; Norma B Romero; Thomas L Winder; Katarina Pelin; Carina Wallgren-Pettersson
Journal:  Hum Mutat       Date:  2014-12       Impact factor: 4.878

9.  Congenital myopathy caused by a novel missense mutation in the CFL2 gene.

Authors:  C W Ockeloen; H J Gilhuis; R Pfundt; E J Kamsteeg; P B Agrawal; A H Beggs; A Dara Hama-Amin; A Diekstra; N V A M Knoers; M Lammens; N van Alfen
Journal:  Neuromuscul Disord       Date:  2012-05-04       Impact factor: 4.296

Review 10.  Centronuclear (myotubular) myopathy.

Authors:  Heinz Jungbluth; Carina Wallgren-Pettersson; Jocelyn Laporte
Journal:  Orphanet J Rare Dis       Date:  2008-09-25       Impact factor: 4.123

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.